Edwards Lifesciences (EW) Earnings Date, Estimates & Call Transcripts → Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (From Banyan Hill Publishing) (Ad) Free EW Stock Alerts $86.43 -1.58 (-1.80%) (As of 04/26/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateJul. 24EstimatedActual EPS (Apr. 25) $0.66 Beat By $0.02 Consensus EPS (Apr. 25) $0.64 Read Call TranscriptListen to Call Get Edwards Lifesciences Earnings AlertsEnter your email address below to receive the latest news and earnings results for EW and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueEW Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.EW Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad DTIA new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… Click here to see me place one of these trades LIVE on camera. Edwards Lifesciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20243$0.64$0.65$0.640.620 - 0.660Q2 20243$0.70$0.71$0.700.670 - 0.710Q3 20243$0.68$0.71$0.69 Q4 20243$0.71$0.73$0.72 FY 202412$2.73$2.80$2.76 Q1 20253$0.72$0.77$0.75 Q2 20253$0.77$0.79$0.78 Q3 20253$0.76$0.79$0.77 Q4 20253$0.77$0.80$0.79 FY 202512$3.02$3.15 $3.09EW Earnings Date and InformationEdwards Lifesciences last issued its quarterly earnings results on April 25th, 2024. The medical research company reported $0.66 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.64 by $0.02. The company had revenue of $1.60 billion for the quarter, compared to analysts' expectations of $1.58 billion. Edwards Lifesciences has generated $2.32 earnings per share over the last year ($2.32 diluted earnings per share) and currently has a price-to-earnings ratio of 37.3. Earnings for Edwards Lifesciences are expected to grow by 12.68% in the coming year, from $2.76 to $3.11 per share. Edwards Lifesciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 24th, 2024 based off prior year's report dates.Read More Edwards Lifesciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 7/24/2024Estimated)------- 4/25/2024Q1 2024$0.64$0.66+$0.02$0.74$1.58 billion$1.60 billion 2/6/2024Q4 2023$0.64$0.64-$0.67$1.50 billion$1.53 billion 10/25/2023Q3 2023$0.59$0.59-$0.55$1.48 billion$1.48 billion 7/26/2023Q2 2023$0.65$0.66+$0.01$0.82$1.51 billion$1.53 billion 4/26/2023Q1 2023$0.61$0.62+$0.01$0.68$1.39 billion$1.46 billion 1/31/2023Q4 2022$0.61$0.64+$0.03$0.63$1.33 billion$1.35 billion Get the Latest News and Ratings for EW and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Edwards Lifesciences and its competitors with MarketBeat's FREE daily newsletter. 10/27/2022Q3 2022$0.62$0.61($0.01)$0.67$1.34 billion$1.32 billion7/28/2022Q2 2022$0.63$0.63-$0.61$1.40 billion$1.37 billion 4/26/2022Q1 2022$0.58$0.60+$0.02$0.61$1.31 billion$1.34 billion 1/26/2022Q4 2021$0.55$0.51($0.04)$0.49$1.34 billion$1.33 billion 10/27/2021Q3 2021$0.53$0.54+$0.01$0.54$1.32 billion$1.31 billion 7/29/2021Q2 2021$0.55$0.64+$0.09$0.50$1.29 billion$1.38 billion Edwards Lifesciences Earnings - Frequently Asked Questions When is Edwards Lifesciences's earnings date? Edwards Lifesciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 24th, 2024 based off last year's report dates. Learn more on EW's earnings history. Did Edwards Lifesciences beat their earnings estimates last quarter? In the previous quarter, Edwards Lifesciences (NYSE:EW) reported $0.66 earnings per share (EPS) to beat the analysts' consensus estimate of $0.64 by $0.02. Learn more on analysts' earnings estimate vs. EW's actual earnings. How can I listen to Edwards Lifesciences's earnings conference call? The conference call for Edwards Lifesciences's latest earnings report can be listened to online. Listen to Conference Call How can I read Edwards Lifesciences's conference call transcript? The conference call transcript for Edwards Lifesciences's latest earnings report can be read online. Read Transcript How much revenue does Edwards Lifesciences generate each year? Edwards Lifesciences (NYSE:EW) has a recorded annual revenue of $6.00 billion. How much profit does Edwards Lifesciences generate each year? Edwards Lifesciences (NYSE:EW) has a recorded net income of $1.40 billion. EW has generated $2.32 earnings per share over the last four quarters. What is Edwards Lifesciences's price-to-earnings ratio? Edwards Lifesciences (NYSE:EW) has a trailing price-to-earnings ratio of 37.25 and a forward price-to-earnings ratio of 31.32. The price/earnings-to-growth ratio is 4.29. What is Edwards Lifesciences's EPS forecast for next year? Edwards Lifesciences's earnings are expected to grow from $2.76 per share to $3.11 per share in the next year, which is a 12.68% increase. More Earnings Resources from MarketBeat Related Companies: ISRG Earnings Results ZBH Earnings Results ALGN Earnings Results DXCM Earnings Results COR Earnings Results IQV Earnings Results TAK Earnings Results MRNA Earnings Results CNC Earnings Results IDXX Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted This page (NYSE:EW) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHis win rate puts Warren Buffett to shame… Investing DailyThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm PressEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edwards Lifesciences Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.